Member access

4-Traders Homepage  >  Shares  >  Tokyo  >  Astellas Pharma Inc    4503   JP3942400007

SummaryChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Latest news on ASTELLAS PHARMA INC
2d ago ASTELLAS PHARMA : Announces Personnel Changes and Organization Changes
2d ago UK cancer drug fund gets extra 160 million pounds
3d ago ASTELLAS PHARMA : Researchers at Astellas Pharma, Inc. Report New Data on Invest..
3d ago ASTELLAS PHARMA : Studies from Astellas Pharma, Inc. Update Current Data on Clin..
3d ago ASTELLAS PHARMA : Announces Personnel Changes and Organization Changes (pdf 85KB..
08/21 AMBIT BIOSCIENCES : Posts 2Q 2014 Results
08/18 AMBIT BIOSCIENCES : Releases 2Q 2014 Results
08/16 ASTELLAS PHARMA : Cancer Research UK and Cancer Research Technology Partner with..
08/14 ASTELLAS PHARMA : Basilea reports 2014 half-year financials ceftobiprole launch ..
08/13 ASTELLAS PHARMA : Cancer Research UK and Cancer Research Technology Join Forces ..
08/13 ASTELLAS PHARMA : Research Data from Astellas Pharma, Inc. Update Understanding ..
08/13 ASTELLAS PHARMA : Ambit Biosciences Announces Second Quarter 2014 Operating Resu..
08/11 ASTELLAS PHARMA : OSI Pharmaceuticals Assigned Patent
08/11 ASTELLAS PHARMA : Cancer research uk and cancer research technology join forces ..
08/08 ASTELLAS PHARMA : Cancer research uk and cancer research technology join forces ..
08/07 ASTELLAS PHARMA : Corporate Whistleblower Center Urges Physicians Who Have Proof..
08/06 ASTELLAS PHARMA : Reports Summarize Nephrology Findings from Astellas Pharma, In..
08/01 ASTELLAS PHARMA : Vical Reports Second Quarter 2014 Financial Results and Progre..
07/28 ASTELLAS PHARMA : US Inc. Pays $7.3 Million to Resolve False Claims Act Allegati..
07/26 ASTELLAS PHARMA : US Inc. Pays $7.3 Million to Resolve False Claims Act Allegati..
07/23 ASTELLAS PHARMA : New Findings on Pelvic Organ Prolapse Described by Investigato..
07/18 ASTELLAS PHARMA : NC to Share in $7.3 Million Medicaid Fraud Settlement from Ast..
07/16 ASTELLAS PHARMA : Study Data from Astellas Pharma, Inc. Update Understanding of ..
07/15 ASTELLAS PHARMA : Submits Supplemental New Drug Application for Irribow/Irribow ..
07/15 ASTELLAS PHARMA : Attorney General Pam Bondi Announces $7.3 Million Settlement w..
07/15 ASTELLAS PHARMA : Attorney General J.B. Van Hollen Announces Astellas Pharma to ..
07/14 ASTELLAS PHARMA : Submits Supplemental New Drug Application for Irribow®/Irribow..
07/12 ASTELLAS PHARMA : Pays $7.3 Million to Resolve False Claims Act Allegations Rela..
07/09 ASTELLAS PHARMA : Submits U.S. New Drug Application for Isavuconazole for the Tr..
07/09 ASTELLAS PHARMA : New Clinical Trials and Studies Study Findings Recently Were R..
07/04 ASTELLAS PHARMA : - Contents of Subscription Rights to Shares (Stock Option Sche..
07/03 ASTELLAS PHARMA : Contents of Subscription Rights to Shares (Stock Option Scheme..
07/01 ASTELLAS PHARMA : in the Americas Names Tatjana Dragovic as VP, Regional Complia..
06/27 ASTELLAS PHARMA : Tatjana Dragovic, J.D., Named Vice President, Regional Complia..
06/26 ASTELLAS PHARMA : -Announcement of an Application for the Additional Indication ..
06/25 ASTELLAS PHARMA : Announcement of an Application for the Additional Indication f..
06/24 ASTELLAS PHARMA : -Notice of Completion of Acquisition of Own Shares (Under the ..
06/23 ASTELLAS PHARMA : Notice of Completion of Acquisition of Own Shares (pdf 62KB)
06/18 ASTELLAS PHARMA : Allotment of Subscription Rights to Shares (Stock Option Schem..
06/13 ASTELLAS PHARMA : UCB - First phase 3 study evaluating Cimzia (certolizumab pego..
06/11 ASTELLAS PHARMA : Protein Sciences Partners File for Marketing Approval of Flubl..
06/03 ASTELLAS PHARMA : OSI Pharmaceuticals Assigned Patent
06/02 ASTELLAS PHARMA : and UMN Announce Submission of Application for Marketing Appro..
05/30 ASTELLAS PHARMA : Fistula Foundation partner to treat obstetric fistula in Kenya
05/30 ASTELLAS PHARMA : and UMN Announce Submission of Application for Marketing Appro..
05/28 ASTELLAS PHARMA : Findings from Astellas Pharma, Inc. Update Understanding of Pa..
05/27 ASTELLAS PHARMA : ANNOUNCES GROUNDBREAKING €1.5m PROGRAMME TO TACKLE OBSTETRIC F..
05/22 ASTELLAS PHARMA : Announces Launch of XTANDI® (enzalutamide) Capsules in Japan f..
05/22 ASTELLAS PHARMA : Data from Astellas Pharma, Inc. Advance Knowledge in Powder Te..
05/21 ASTELLAS PHARMA : Researchers' Work from Astellas Pharma, Inc. Focuses on Enzyme..
05/21 ASTELLAS PHARMA : New Quality of Life Findings from Astellas Pharma, Inc. Descri..
05/14 ASTELLAS PHARMA : Announces Personnel Changes (pdf 42KB)
05/12 ASTELLAS PHARMA : Announces Acquisition of Own Shares (pdf 63KB)
05/12 ASTELLAS PHARMA : Announces Cancellation of Treasury Shares (pdf 25KB)
05/12 ASTELLAS PHARMA : Announces Issuance of Stock Acquisition Rights for Stock Optio..
05/07 ASTELLAS PHARMA : Data on B-Cell Lymphoma Discussed by Researchers at Astellas P..
04/30 ASTELLAS PHARMA : Research Results from Astellas Pharma, Inc. Update Knowledge o..
04/28 ASTELLAS PHARMA : Nominates Director and Corporate Auditors
04/25 ASTELLAS PHARMA : Nominates Director and Corporate Auditors (pdf 40KB)
04/23 ASTELLAS PHARMA : Named National Presenting Sponsor of the National Kidney Found..
04/23 ASTELLAS PHARMA : Studies from Astellas Pharma, Inc. in the Area of Quality of L..
04/23 ASTELLAS PHARMA : US, Inc. reaches agreement with U.S. Department of Justice
04/17 ASTELLAS PHARMA : -Launch of Suglat Tablets, a Selective SGLT2 Inhibitor for Tre..
04/17 ASTELLAS PHARMA : US, Inc. to Pay $7.3 Million to Resolve False Claims Act Alleg..
04/16 ASTELLAS PHARMA : Launch of Suglat® Tablets, a Selective SGLT2 Inhibitor for Tre..
04/16 ASTELLAS PHARMA : Findings from Astellas Pharma, Inc. Yields New Data on HIV/AID..
04/16 ASTELLAS PHARMA : US Inc. to Pay $7.3 Million to Resolve False Claims Act Allega..
04/16 ASTELLAS PHARMA : Illinois-based Astellas to pay $7.3M settlement
04/16 ASTELLAS PHARMA : to pay $7.3M in drug-marketing settlement
04/15 ASTELLAS PHARMA : Named National Presenting Sponsor of the National Kidney Found..
04/09 Seattle Genetics Showcases Antibody-Drug Conjugate (ADC) Program and Technolo..
04/08 Seattle Genetics Highlights Antibody-Drug Conjugate (ADC) Program and Technol..
04/04 ASTELLAS PHARMA : Announces marketing authorisation application for xtandi (enza..
04/03 ASTELLAS PHARMA : ANNOUNCES MARKETING AUTHORISATION APPLICATION FOR XTANDI&trade..
03/31 ASTELLAS PHARMA : Establishment of Regenerative Medicine Unit
1  2  3  4Next
Advertisement
Chart
Duration : Period :
Astellas Pharma Inc Technical Analysis Chart | 4503 | JP3942400007 | 4-Traders
Income Statement Evolution
Astellas Pharma Inc : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF